These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Committee for Medicinal Products for Human Use (CHMP) guideline on Data Monitoring Committees. ; ; Stat Med; 2006 May; 25(10):1639-45. PubMed ID: 16639775 [No Abstract] [Full Text] [Related]
6. Standard 3: data monitoring committees. Ellenberg S; Fernandes RM; Saloojee H; Bassler D; Askie L; Vandermeer B; Offringa M; Van der Tweel I; Altman DG; van der Lee JH; Pediatrics; 2012 Jun; 129 Suppl 3():S132-7. PubMed ID: 22661759 [No Abstract] [Full Text] [Related]
7. [Performing clinical trials efficiently in Japan--independent clinical trials and GCP]. Kanai M; Suzuki-Nishimura T Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):449-54. PubMed ID: 17644939 [TBL] [Abstract][Full Text] [Related]
8. [Is good clinical practice a problem?]. Bach KF; Friis K; Jørgensen A Ugeskr Laeger; 2004 Apr; 166(18):1649. PubMed ID: 15174396 [No Abstract] [Full Text] [Related]
10. IRBs and monitoring the safety of clinical trials. Maloney DM Hum Res Rep; 2003 Jan; 18(1):3. PubMed ID: 12755095 [No Abstract] [Full Text] [Related]
11. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?]. Schwarz S; Frölich L; Striebel JP; Hennerici MG Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346 [No Abstract] [Full Text] [Related]
12. Data Safety Monitoring Board (DSMB). Welch KM Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():46-7. PubMed ID: 15512871 [No Abstract] [Full Text] [Related]
13. [Data monitoring committees. Third pillar in the methodical conduct of clinical trials]. Fischer T Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):793-6. PubMed ID: 18563280 [TBL] [Abstract][Full Text] [Related]
14. [New regulations on drug research]. Bach KF; Friis K; Jørgensen A Ugeskr Laeger; 2004 Apr; 166(18):1657-9. PubMed ID: 15174399 [No Abstract] [Full Text] [Related]
15. [Public clinical trials: which kind of monitoring should be used?]. Cornu C; Binquet C; Thalamas C; Vigouroux C; Gaillard S; Ginhoux T; Vaz B; Jossan C; Félin A; Sailly A; Gueyffier F; Journot V; Kassaï B Therapie; 2013; 68(3):135-41. PubMed ID: 23886457 [TBL] [Abstract][Full Text] [Related]
16. [Organization, administration, and performance of clinical studies]. Bachner M; Steininger T; Gneist M Onkologie; 2008; 31 Suppl 2():3-6. PubMed ID: 18487861 [TBL] [Abstract][Full Text] [Related]
17. Out in the open. Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130 [No Abstract] [Full Text] [Related]
18. An introductory note to CHMP guidelines: choice of the non-inferiority margin and data monitoring committees. Brown D; Volkers P; Day S Stat Med; 2006 May; 25(10):1623-7. PubMed ID: 16639776 [TBL] [Abstract][Full Text] [Related]
19. When to conduct a clinical trial. Boutrand JP Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271 [TBL] [Abstract][Full Text] [Related]